Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Obsessive-Compulsive Disorder and CYP2D6[original query] |
---|
The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism. Genetic testing and molecular biomarkers 2012 Jul . Müller DJ, Brandl EJ, Hwang R, Tiwari AK, Sturgess JE, Zai CC, Lieberman JA, Kennedy JL, Richter MA |
Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder. The pharmacogenomics journal 2014 Apr 14 (2): 176-81. Brandl E J, Tiwari A K, Zhou X, Deluce J, Kennedy J L, Müller D J, Richter M |
Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients. Frontiers in pharmacology 2022 13 966622. Li Xiao-Lin, Huang Shan-Qing, Xiao Tao, Wang Xi-Pei, Kong Wan, Liu Shu-Jing, Zhang Zi, Yang Ye, Huang Shan-Shan, Ni Xiao-Jia, Lu Hao-Yang, Zhang Ming, Wen Yu-Guan, Shang De-W |
- Page last reviewed:Feb 1, 2024
- Content source: